Literature DB >> 12563592

Withdrawal syndrome from tramadol hydrochloride.

Christopher E Barsotti, Mark B Mycyk, Jose Reyes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12563592     DOI： 10.1053/ajem.2003.50039

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN： 0735-6757            Impact factor:   2.469


× No keyword cloud information.
  13 in total

1.  Angioedema induced by tramadol--a potentially life-threatening condition.

Authors:  Pär Hallberg; Gunilla Brenning
Journal:  Eur J Clin Pharmacol       Date:  2005-01-19       Impact factor: 2.953

2.  Tramadol withdrawal in a neonate after long-term analgesic treatment of the mother.

Authors:  C Willaschek; E Wolter; R Buchhorn
Journal:  Eur J Clin Pharmacol       Date:  2008-12-16       Impact factor: 2.953

Review 3.  Tramadol for the management of premature ejaculation: a timely systematic review.

Authors:  E W Kirby; C C Carson; R M Coward
Journal:  Int J Impot Res       Date:  2015-05-14       Impact factor: 2.896

4.  All-Cause Mortality Associated with Tramadol Use: A Case-Crossover Study.

Authors:  Sohyun Jeong; Ha Jin Tchoe; Junqing Li; Ju-Young Shin
Journal:  Drug Saf       Date:  2019-06       Impact factor: 5.606

5.  Physical dependence potential of daily tramadol dosing in humans.

Authors:  Ryan K Lanier; Michelle R Lofwall; Miriam Z Mintzer; George E Bigelow; Eric C Strain
Journal:  Psychopharmacology (Berl)       Date:  2010-06-30       Impact factor: 4.530

6.  Abuse liability and reinforcing efficacy of oral tramadol in humans.

Authors:  Shanna Babalonis; Michelle R Lofwall; Paul A Nuzzo; Anthony J Siegel; Sharon L Walsh
Journal:  Drug Alcohol Depend       Date:  2012-10-23       Impact factor: 4.492

Review 7.  Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol.

Authors:  David H Epstein; Kenzie L Preston; Donald R Jasinski
Journal:  Biol Psychol       Date:  2006-02-23       Impact factor: 3.251

8.  Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: a two-phase randomized controlled trial.

Authors:  Michelle R Lofwall; Shanna Babalonis; Paul A Nuzzo; Anthony Siegel; Charles Campbell; Sharon L Walsh
Journal:  Drug Alcohol Depend       Date:  2013-06-04       Impact factor: 4.492

9.  Tramadol: a Potential Neurotoxic Agent Affecting Prefrontal Cortices in Adult Male Rats and PC-12 Cell Line.

Authors:  Fakhroddin Aghajanpour; Mahdi Eskandarian Boroujeni; Ali Jahanian; Reza Soltani; Samira Ezi; Aysan Khatmi; Mohammad-Amin Abdollahifar; Seyed Hamidreza Mirbehbahani; Hossein Toreyhi; Abbas Aliaghaei; Abdollah Amini
Journal:  Neurotox Res       Date:  2020-05-06       Impact factor: 3.911

10.  Chronic Exposure to Tramadol Induces Neurodegeneration in the Cerebellum of Adult Male Rats.

Authors:  Samira Ezi; Mahdi Eskandarian Boroujeni; Aysan Khatmi; Kimia Vakili; Mobina Fathi; Mohammad-Amin Abdollahifar; Fakhroddin Aghajanpour; Reza Soltani; Seyed Hamidreza Mirbehbahani; Fariba Khodagholi; Abbas Aliaghaei; Reza Mastery Farahani
Journal:  Neurotox Res       Date:  2021-04-05       Impact factor: 3.911
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.